HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
J Marc Simard Selected Research
J Marc Simard Research Topics
Disease
34
Brain Edema (Cerebral Edema)
01/2022 - 04/2006
33
Edema (Dropsy)
01/2022 - 01/2004
27
Stroke (Strokes)
10/2022 - 01/2003
20
Traumatic Brain Injuries (Traumatic Brain Injury)
06/2021 - 02/2008
19
Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
12/2021 - 02/2009
18
Hemorrhage
01/2022 - 12/2008
17
Ischemia
01/2020 - 01/2004
16
Infarction (Infarctions)
01/2022 - 04/2006
15
Ischemic Stroke
10/2019 - 12/2002
13
Spinal Cord Injuries (Spinal Cord Injury)
06/2022 - 08/2007
12
Wounds and Injuries (Trauma)
01/2021 - 02/2008
12
Brain Ischemia (Cerebral Ischemia)
01/2020 - 01/2011
9
Brain Injuries (Brain Injury)
07/2022 - 06/2003
9
Neuroinflammatory Diseases
01/2021 - 07/2012
8
Necrosis
02/2022 - 08/2007
8
Hypoxia (Hypoxemia)
05/2015 - 01/2004
7
Inflammation (Inflammations)
01/2022 - 02/2009
6
Hypertension (High Blood Pressure)
12/2013 - 01/2003
5
Pain (Aches)
07/2022 - 01/2019
5
Spinal Injuries (Spinal Injury)
01/2021 - 01/2017
5
Brain Contusion
01/2020 - 12/2009
5
Contusions
01/2020 - 02/2012
4
Hypothermia
06/2022 - 11/2015
4
Cerebral Infarction
01/2021 - 01/2011
4
Neoplasms (Cancer)
01/2018 - 11/2005
4
Brain Neoplasms (Brain Tumor)
12/2017 - 10/2013
4
Brain Diseases (Brain Disorder)
05/2015 - 12/2011
3
Aneurysm (Aneurysms)
10/2019 - 12/2013
3
Heart Arrest (Cardiac Arrest)
01/2018 - 10/2011
3
Type 2 Diabetes Mellitus (MODY)
01/2018 - 10/2013
3
Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
08/2015 - 02/2009
2
Headache (Headaches)
07/2022 - 12/2021
2
COVID-19
02/2022 - 01/2022
2
Cytokine Release Syndrome
02/2022 - 01/2022
2
Acute Pain
12/2021 - 11/2021
2
Neurocognitive Disorders (Clerambault Syndrome)
10/2021 - 01/2021
2
Neuralgia (Stump Neuralgia)
01/2021 - 01/2019
2
Thrombocytopenia (Thrombopenia)
01/2021 - 12/2013
2
Venous Thrombosis (Deep-Vein Thrombosis)
01/2021 - 12/2013
2
Gliosis
01/2021 - 09/2017
2
Hydrocephalus (Hydrocephaly)
01/2020 - 08/2017
2
Intracranial Hypertension
01/2019 - 10/2015
2
Glioma (Gliomas)
01/2018 - 01/2017
2
Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
09/2017 - 11/2015
2
Hemorrhagic Stroke
03/2015 - 10/2013
2
Craniocerebral Trauma (Head Injury)
12/2009 - 05/2009
Drug/Important Bio-Agent (IBA)
46
Glyburide (Glibenclamide)
FDA Link
Generic
01/2022 - 04/2006
26
Sulfonylurea Receptors
IBA
12/2020 - 04/2006
21
Adenosine Triphosphate (ATP)
IBA
01/2019 - 01/2004
17
Proteins (Proteins, Gene)
FDA Link
02/2022 - 01/2006
9
Pharmaceutical Preparations
IBA
10/2022 - 12/2013
8
Heparin (Liquaemin)
FDA Link
Generic
01/2021 - 12/2010
7
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
02/2022 - 02/2009
6
Cations
IBA
08/2015 - 01/2004
5
Biomarkers (Surrogate Marker)
IBA
01/2022 - 06/2006
5
Ion Channels (Ion Channel)
IBA
01/2020 - 08/2009
4
Cytokines
IBA
02/2022 - 01/2020
4
Explosive Agents (Explosives)
IBA
08/2019 - 10/2011
4
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
12/2018 - 09/2012
4
Tissue Plasminogen Activator (Alteplase)
FDA Link
01/2018 - 09/2012
4
Immunoglobulin G (IgG)
IBA
08/2015 - 02/2009
3
Opioid Analgesics (Opioids)
IBA
07/2022 - 11/2021
3
Interleukin-6 (Interleukin 6)
IBA
02/2022 - 01/2021
3
Aquaporins (Water Channels)
IBA
11/2021 - 02/2015
3
Toll-Like Receptor 4
IBA
12/2020 - 03/2015
3
Oligodeoxyribonucleotides
IBA
01/2020 - 04/2010
3
Biological Products
IBA
12/2019 - 11/2005
3
Caspase 3 (Caspase-3)
IBA
07/2012 - 02/2009
3
Angiotensin II
IBA
01/2006 - 01/2003
2
Betulinic Acid
IBA
10/2022 - 01/2019
2
Antioxidants
IBA
10/2022 - 01/2019
2
Analgesics (Analgesic Drugs)
IBA
07/2022 - 11/2021
2
NF-kappa B (NF-kB)
IBA
02/2022 - 07/2012
2
HMGB1 Protein (HMG1)
IBA
01/2022 - 01/2020
2
Chemokines
IBA
01/2022 - 01/2021
2
6,7-dihydroxyflavone
IBA
10/2021 - 01/2021
2
Chemokine CCL2 (Monocyte Chemoattractant Protein 1)
IBA
01/2021 - 09/2017
2
Ligands
IBA
01/2020 - 03/2015
2
Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
IBA
01/2020 - 01/2016
2
Transient Receptor Potential Channels
IBA
01/2019 - 08/2007
2
Glial Fibrillary Acidic Protein
IBA
01/2019 - 10/2008
2
Elements
IBA
10/2018 - 04/2014
2
Nitric Oxide Synthase (NO Synthase)
IBA
09/2017 - 01/2016
2
Riluzole
FDA Link
Generic
11/2015 - 01/2012
2
Sodium
IBA
04/2014 - 01/2012
2
Calcium
IBA
01/2013 - 08/2007
2
Potassium
IBA
01/2013 - 01/2007
2
fluoro-jade C
IBA
07/2012 - 10/2011
2
Angiotensins
IBA
10/2003 - 05/2003
2
Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)
IBA
05/2003 - 01/2003
Therapy/Procedure
19
Therapeutics
07/2022 - 12/2010
10
Decompressive Craniectomy
01/2022 - 05/2009
6
Decompression
01/2021 - 01/2013
4
Craniotomy
11/2021 - 12/2009
3
Drug Therapy (Chemotherapy)
07/2022 - 01/2016
3
Surgical Decompression
01/2019 - 09/2012
3
Cardiopulmonary Resuscitation (CPR)
01/2018 - 10/2011
2
Intravenous Administration
10/2022 - 01/2019
2
Minimally Invasive Surgical Procedures
09/2019 - 02/2016
2
Artificial Respiration (Mechanical Ventilation)
05/2015 - 12/2011